Combination therapy of ofatumumab and daratumumab in patients with severe anti-NMDA receptor encephalitis
N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis (NMDARE) is an autoimmune disorder in which approximately 25% of patients develop refractory disease with severe prolonged neurological deficits. Currently, there is no consensus on optimal tr…